Health Condition 1: G620- Drug-induced polyneuropathy
Conditions
Interventions
None listed
Sponsors
Bharatiya Sanskriti Darshan Trusts Integrated Cancer Treatment and Research Centre
Dr Anjali Deshpande PhD Guide Professor and HOD Dept of Kayachikitsa
Eligibility
Inclusion criteria
Inclusion criteria: Histologically confirmed cancer patients, irrespective of stage of cancer, undergoing Taxane or Platinum-based chemotherapy, or within 2 years after completion of this protocol and has clinical diagnosis of CIPN of grade 1 to 3 according to NCI-CTC version 4.03
Exclusion criteria
Exclusion criteria: 1. Patient having a history of peripheral neuropathy unrelated to chemotherapy, such as diabetic neuropathy, severe renal failure, liver impairment and alcoholism. 2. Brain and central nervous system metastases. 3. Known conditions such as auto-immune diseases, infections, bone / joint diseases causing injury or pressure on the nerve, exposure to poisons, and low vitamin levels.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of Ayurvedic treatment in managing symptoms of CIPN and improving QoL of cancer patients.Timepoint: To assess the efficacy of Ayurvedic treatment in managing symptoms of CIPN and improving QoL of cancer patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Ayurvedic treatment in patients with CIPN by electrodiagnostic parameters i.e Nerve Conduction Velocity (NCV) test.Timepoint: Nerve Conduction Velocity (NCV) test will be done at time point namely baseline (A), 3 months (B), 6 months (C) and 1 year (E) after enrolment in all the groups. | — |
Countries
India
Contacts
Public ContactDr Anjali Aniruddha Deshpande
Bharatiya Sanskriti Darshan Trusts Integrated Cancer Treatment and Research Centre
Outcome results
None listed